Austin, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Viral Vectors and Plasmid DNA Manufacturing Market Size & Growth Analysis: According to SNS Insider, the Viral Vectors and Plasmid DNA Manufacturing ...
Ottawa, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global viral vectors and plasmid DNA manufacturing market size surpassed USD 6.26 billion in 2024 and is estimated to grow from USD 7.26 billion in 2025 ...
Projected Growth: Viral Vectors and Plasmid DNA Manufacturing Market Set to Soar by 2033 | Market.us
An Increase in Demand and Opportunities for the Global Viral Vectors and Plasmid DNA Manufacturing Market by 2024,” offers a comprehensive analysis of the market by evaluating research and information ...
DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...
Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing ...
According to the report, the global viral vectors and plasmid DNA manufacturing market size was valued at $5.3 billion in 2023, and is projected to reach $34.0 billion by 2033, growing at a CAGR of 20 ...
Non-viral gene therapy is being considered as a treatment for cystic fibrosis. In clinical studies and in studies using the mouse airways as a model, current formulations result in only transient ...
Increase in funding for R&D activities, surge in awareness regarding gene therapy, and rise in prevalence of cancer, viral infections, and genetic disorders drive the growth of global viral vectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results